While Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) still rule the weight-loss drug market with their respective GLP-1 medications, competition could soon be heating up as rival products near ...
Find insight on Baxter International, ResMed, Fisher & Paykel Healthcare and more in the latest Market Talks covering Health ...